Phospholipase A2 enzymes differently impact PUFA release and oxylipin formation ex vivo in rat hearts
Prostaglandins, Leukotrienes and Essential Fatty Acids · 2023
DOI: 10.1016/j.plefa.2023.102555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2023. Verfasst von Anne Manson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Food and Human Nutritional Sciences, University of Manitoba, Winnipeg MB, Canada; Canadian Centre for Agri-Food Research in Health and Medicine (CCAR…. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Phospholipases A2, Secretory. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Phospholipase A2 (PLA2) enzymes cleave cell membrane phospholipids and release polyunsaturated fatty acids (PUFA), which can be converted into oxylipins. However, little is known about PLA2 preference for PUFA, and even less is known about how this further impacts oxylipin formation. Therefore, we investigated the role of different PLA2 groups in PUFA release and oxylipin formation in rat hearts. Sprague-Dawley rat heart homogenates were incubated without or with varespladib (VAR), methyl arachidonyl fluorophosphonate (MAFP) or EDTA. Free PUFA and oxylipins were determined by HPLC-MS/MS, and isoform expressions by RT-qPCR. Inhibition of sPLA2 IIA and/or V by VAR reduced the release of ARA and DHA, but only DHA oxylipins were inhibited. MAFP reduced the release of ARA, DHA, ALA, and EPA, and the formation of ARA, LA, DGLA, DHA, ALA, and EPA oxylipins. Interestingly, cyclooxygenase and 12-lipoxygenase oxylipins were not inhibited. mRNA expression levels of sPLA2 and iPLA2 isoforms were highest whereas levels of cPLA2 were low, consistent with activity. In conclusion, sPLA2 enzymes lead to the formation of DHA oxylipins, while iPLA2 is likely responsible for the formation of most other oxylipins in healthy rat hearts. Oxylipin formation cannot be implied from PUFA release, thus, both should be evaluated in PLA2 activity studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Food and Human Nutritional Sciences, University of Manitoba, Winnipeg MB, Canada; Canadian Centre for Agri-Food Research in Health and Medicine (CCARM), Winnipeg MB, Canada.
- Food and Human Nutritional Sciences, University of Manitoba, Winnipeg MB, Canada; Canadian Centre for Agri-Food Research in Health and Medicine (CCARM), Winnipeg MB, Canada. Electronic address: harold.aukema@umanitoba.c…
Zitieren
APA
Manson, A., Winter, T., & Aukema, H. M. (2023). Phospholipase A2 enzymes differently impact PUFA release and oxylipin formation ex vivo in rat hearts. Prostaglandins, Leukotrienes and Essential Fatty Acids. https://doi.org/10.1016/j.plefa.2023.102555
Vancouver
Manson A, Winter T, Aukema HM. Phospholipase A2 enzymes differently impact PUFA release and oxylipin formation ex vivo in rat hearts. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2023. doi:10.1016/j.plefa.2023.102555
BibTeX
@article{Manson2023,
author = {Manson, Anne and Winter, Tanja and Aukema, Harold M},
title = {Phospholipase A2 enzymes differently impact PUFA release and oxylipin formation ex vivo in rat hearts},
journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
year = {2023},
doi = {10.1016/j.plefa.2023.102555}
}
EUVIMED